IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Commercial-stage French biotech developing vaccines for infectious diseases.
Industry: Health Care
Latest Trade: $7.71 0.00 (0.0%)
First Day Return: +7.3%
Return from IPO: -70.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/09/2021 |
Offer Price | $26.41 |
Price Range $24.04 - $28.85 | |
Offer Shares (mm) | 3.5 |
Deal Size ($mm) | $94 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/05/2021 |
Offer Price | $26.41 |
Price Range $24.04 - $28.85 | |
Offer Shares (mm) | 3.5 |
Deal Size ($mm) | $94 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Goldman Sachs |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Saint-Herblain, France |
Founded | 1999 |
Employees | 579 |
Website www.valneva.com |